Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report

doi:10.12998/wjcc.v12.i20.4405

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (201)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

145

Figures (1-2)

Sum=178

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=12

Jul 16, 2024 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jul 16, 2024; 12(20): 4405-4411
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4405

Full Size Figure Download Figure

Figure 2 Pathology of lung biopsy during patient treatment. A: Bronchoscopic lung tissue biopsy on September 17, 2020; B: Percutaneous lung biopsy on October 18, 2023.

Citation: Ji XZ, Liu ZD, Ye YP, Li Q, Liu XJ, Zhou MH, Jin Y. Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report. World J Clin Cases 2024; 12(20): 4405-4411
URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4405.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4405